AI-CVD vs Study Watch
AI Verdict
Choose AI-CVD if…
Choose AI-CVD if your primary goal is to opportunistically screen for cardiovascular and multisystem diseases by leveraging existing chest and abdominal CT scans. This tool is ideal for identifying hidden health risks without requiring additional imaging, radiation, or workflow disruption, providing automated measurements like Coronary Artery Calcium (CAC) scoring and cardiac chamber volumetry.
View AI-CVD →Choose Study Watch if…
Choose Study Watch if you require a prescription-only, sensor-based wearable for continuous, non-invasive physiological monitoring within clinical research settings. This device is best suited for collecting long-term, detailed data such as ECG, heart rate, and movement for analysis in a cloud platform, enabling in-depth investigation of cardiac, neurological, or sleep-related conditions in research participants.
View Study Watch →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AI-CVD | Study Watch |
|---|---|---|
| Deployment | Unknown | The Study Watch is a wrist-worn, multi-sensor wearable device used for data collection in clinical trials. Data from the watch is encrypted and sent securely to the Verily Cloud using a USB syncing and charging cradle and a wireless connectivity bridge (Verily Study Hub). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
AI-CVDAI-CVD offers superior usability by integrating into existing CT scan workflows without requiring additional imaging, radiation, contrast, or workflow disruption. Study Watch, as a wearable, necessitates active patient engagement for wearing, charging, and data collection, adding a layer of user responsibility.
Clinical Value
AI-CVDAI-CVD offers broad clinical value by opportunistically screening for a wide range of cardiovascular and multisystem diseases from existing CT scans, enabling early detection without additional patient burden. While Study Watch provides valuable continuous physiological monitoring for research and specific conditions, AI-CVD's ability to extract extensive, actionable insights from routine imaging for a larger population gives it an edge in widespread clinical impact.
Pricing & Value
AI-CVDAI-CVD explicitly highlights its value proposition of being affordable and requiring no extra cost for patients or physicians by leveraging existing CT scans. This contrasts with Study Watch's non-public pricing for clinical research and partnerships, which doesn't offer the same transparent cost-saving message for broader clinical adoption.
Enterprise Readiness
TieBoth tools are cloud-deployed and FDA-cleared, indicating a baseline for enterprise readiness. While Study Watch explicitly states BAA and HIPAA compliance, the ongoing lawsuit alleging breaches introduces a notable concern. AI-CVD's 'likely, contact vendor' for compliance suggests it meets standards, and its integration into existing radiology workflows may simplify deployment, balancing out the explicit but complicated compliance claims of Study Watch.
Innovation
AI-CVDAI-CVD's innovation lies in its ability to extract extensive, clinically actionable insights for opportunistic screening from *already existing* CT scans, transforming routine imaging into a powerful multi-disease prevention platform without additional patient burden or cost. While Study Watch offers innovative continuous multi-sensor monitoring in a wearable for research, AI-CVD's approach to maximizing value from existing data for broad population health is arguably more disruptive and impactful in a clinical setting.
Support & Docs
Study WatchVerily Study Watch demonstrates stronger support and documentation, offering explicit mentions of forums, tutorials, product documentation, and a user manual. AI-CVD's available information is limited to general contact details and a 'Knowledge Center,' lacking the detailed support structure indicated for Study Watch.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AI-CVD | Study Watch |
|---|---|---|
| Name | AI-CVD | Study Watch |
| Company | HeartLung Corporation | Verily Life Sciences |
| Description | FDA-cleared, AI-powered quantitative imaging platform that performs opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks. | Prescription-only, sensor-based wearable device for non-invasive, continuous physiological monitoring in clinical research, collecting data like ECG, heart rate, and movement for analysis in Verily's cloud platform. |
| Categories | Cardiology AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
| Key Features | Automated CT-derived anatomical and density-based measurements, Opportunistic screening from existing chest and abdominal CT scans, No additional imaging, radiation, contrast, or workflow disruption, Coronary Artery Calcium (CAC) scoring, Aortic wall, aortic valve, and mitral valve calcium analysis, Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle), Epicardial fat volumetry, Aorta and pulmonary artery sizing | Continuous physiological monitoring, Multiple physiological sensors (ECG, heart rate, electrodermal activity, inertial movements), Long battery life (up to one week), Internal data storage and encryption, Cloud-based data processing with algorithms and machine learning, On-demand single-channel ECG, Irregular pulse monitor, E-ink display for minimal power consumption |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Neurology, Sleep Medicine |
Videos
Demos, reviews, and walkthroughs featuring AI-CVD and Study Watch.